Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCF1 pseudogene 3 (FCF1P3) is classified as a pseudogene in the human genome, with the NCBI Gene accession 100128733 and Ensembl ID ENSG00000239997[1][3][9]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but do not encode functional proteins[10]. FCF1P3 resides on chromosome 3 (3q13.12) and is considered a processed pseudogene related to the FCF1 gene, which encodes a component of the small subunit (SSU) processome involved in ribosome biogenesis[3][1][9]. However, FCF1P3 itself does not produce a functional protein, and there are no reports of its involvement in any biological pathway, disease, or as a target of any drug. There is no evidence that FCF1P3 serves as a biomarker, therapeutic target, or has any established clinical relevance. Key points supporting this assessment: - FCF1P3 is specifically listed as a pseudogene, with no indication of functional protein product or disease association[1][3][9]. - It is unrelated to common therapeutic target classes such as receptors, enzymes, ion channels, or transporters. - There is no evidence in major databases or literature of biological activity, biomarker status, or drug interaction relevant to FCF1P3. - Confusion with FCF1 (functional gene) or other pseudogenes is possible, but FCF1P3 is specifically annotated as non-coding and nonfunctional[1][3][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCF1 pseudogene 3 (FCF1P3).